Fine particle pharmaceutical excipient with superior flow properties and enhanced compactibility for direct compression
Excellent flow properties due to fine particle size, ideal for high-speed tablet production.
Superior compaction properties for strong tablet formation with minimal binding agents.
Fine particle size ensures uniform content distribution in low-dose formulations.
Excellent chemical stability and compatibility with various pharmaceutical ingredients.
| Parameter | Specification | Test Method |
|---|---|---|
| Appearance | White, odorless, fine crystalline powder | Visual |
| Identification | Complies with USP/EP standards | IR Spectroscopy |
| pH (1% slurry) | 5.0 - 7.5 | USP <791> |
| Loss on Drying | ≤ 5.0% | USP <731> |
| Residue on Ignition | ≤ 0.1% | USP <281> |
| Heavy Metals | ≤ 10 ppm | USP <231> |
| Particle Size Distribution | D50: 80-100 μm | Laser Diffraction |
| Bulk Density | 0.28 - 0.35 g/mL | USP <616> |
| Tapped Density | 0.40 - 0.55 g/mL | USP <616> |
| Compressibility Index | ≤ 18% | USP <616> |
| Degree of Polymerization | ≥ 350 | USP Method |
| Microbial Limits | Total Aerobic Count: ≤ 1000 CFU/g Yeast & Mold: ≤ 100 CFU/g |
USP <61> |
Optimized for high-speed tablet production with excellent flow and compaction properties.
Ideal for small tablet formulations requiring fine particle size and uniform distribution.
Perfect for low dose active ingredients requiring precise content uniformity and mixing.
Excellent for multilayer tablet formulations with superior layer adhesion properties.
Used as diluent in capsule formulations for improved flow and content uniformity.
Compatible with wet granulation processes as a binder and disintegrant.
Our Microcrystalline Cellulose (MCC 102) meets the highest international pharmaceutical standards and regulatory requirements.
United States Pharmacopeia
European Pharmacopoeia
Japanese Pharmacopoeia
Indian Pharmacopoeia
British Pharmacopoeia
Contact us today for quotes, samples, or technical support